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Summary
Background:Cells control progression through latemitosis by
regulating Cdc20 and Cdh1, the two mitotic activators of the
anaphase-promoting complex (APC). The control of Cdc20
protein levels during the cell cycle is not well understood.
Results: Here, we demonstrate that Cdc20 is degraded in
budding yeast by multiple APC-dependent mechanisms. We
find that the majority of Cdc20 turnover does not involve a
second activator molecule but instead depends on in cis
Cdc20 autoubiquitination while it is bound to its activator-
binding site on the APC core. Unlike in trans ubiquitination of
Cdc20 substrates, the APC ubiquitinates Cdc20 independent
of APC activation by Cdc20’s C box. Cdc20 turnover by this
intramolecular mechanism is cell cycle regulated, contributing
to the decline in Cdc20 levels that occurs after anaphase. Inter-
estingly, high substrate levels in vitro significantly reduce
Cdc20 autoubiquitination.
Conclusion:We show here that Cdc20 fluctuates through the
cell cycle via a distinct form of APC-mediated ubiquitination.
This in cis autoubiquitination may preferentially occur in early
anaphase, following depletion of Cdc20 substrates. This sug-
gests that distinct mechanisms are able to target Cdc20 for
ubiquitination at different points during the cell cycle.Introduction
Chromosome segregation is one of the most tightly regulated
events in the dividing cell. Incorrect entry into anaphase
can have catastrophic cellular consequences ranging from
genomic instability to cell death. Anaphase is initiated by the
anaphase-promoting complex/cyclosome (APC) [1, 2], an E3
ubiquitin ligase composed of at least 13 core subunits [3, 4].
APC function is regulated by association with one of two acti-
vator subunits, Cdc20 or Cdh1 (also known as Hct1) [5–7].
These proteins are thought to function both in the binding of
substrates to the APC [8] and APC activation [9]. Cdc20 asso-
ciates with the APC in early mitosis and triggers anaphase
onset by promoting the destruction of a subset of mitotic cy-
clins and securin (also known as Pds1) [10, 11], resulting in
the activation of Esp1 and the separation of sister chromatids
through cleavage of cohesion [12]. In latemitosis andG1, Cdh1
associates with the APC, promoting mitotic exit and maintain-
ing low Cdk activity.
Both activators contain well-conserved motifs involved in
APC and substrate binding (Figure 1A). APC binding is3These authors contributed equally to this work
*Correspondence: david.toczyski@ucsf.edumediated by both a C-box motif within the activator’s N
terminus [8] and a C-terminal isoleucine-arginine (IR) motif
[13, 14] (Figure 1A). Substrate binding is mediated by a
WD40 domain that is likely to interact directly with degradation
signals found within substrates [15], the most common being
the destruction box (D box, DB) [16] and KEN box [17]. Proces-
sive substrate ubiquitination has also been shown to require
the core APC subunit Doc1 [14, 18], which is thought to func-
tion as a coreceptor for the D box in conjunction with the
WD40 of Cdc20/Cdh1 [19, 20].
The two mitotic APC activators are thought to function anal-
ogously, but they are regulated in distinct ways. Whereas
Cdh1 protein and transcript levels are constitutive, both
Cdc20 transcription and protein levels oscillate throughout
the cell cycle [21, 29]. Cdc20 is absent in G1 but begins to
accumulate in late S phase, its peak coinciding with the initia-
tion of anaphase. Cdh1 is thought to bind an N-terminal D box
within Cdc20, leading to the destruction of Cdc20 in late
mitosis and G1 [22–24]. However, although Cdh1-mediated
turnover of Cdc20 is likely important, several studies have sug-
gested that Cdc20 is also turned over by Cdh1-independent
mechanisms [21, 25, 26]. Regulation of Cdc20 levels is very
important, because high-level overexpression of Cdc20 is
lethal [27] and as little as 3-fold overexpression of Cdc20 is
sufficient to override the spindle assembly checkpoint [28].
Previously, we found that deletion of Cdc20’s IR motif
caused a strong accumulation of Cdc20 in vivo [25], which is
inconsistent with Cdc20 simply being a passive Cdh1 sub-
strate. Here, we show that Cdc20 turnover is fully APC-depen-
dent but does not depend on a second activator molecule.
Although Cdc20 can be targeted by the APC associated with
either Cdh1 or, more poorly, by a second Cdc20 molecule
(i.e., in trans turnover), we find that most turnover in vivo,
and ubiquitination in vitro, is promoted by direct association
with the APC (in cis turnover) (Figure 1B). Consistent with
this model, we show that processive ubiquitination of Cdc20
does not require Doc1. Importantly, we find that Cdc20 levels
oscillate independently of CDC20 transcription and Cdh1
activity, implying that the in cis autoregulation of Cdc20 turn-
over changes during the cell cycle. Additionally this regulation
can be influenced by the presence of APCCdc20 substrates.
These findings uncover another mechanism by which the
activity of the APC is tightly controlled during the cell cycle.
Results
Cdc20 Turnover Depends on the APC
Cdc20 is thought to be destroyed by both APC-dependent
mechanisms [21, 29, 30] and APC-independent mechanisms
[30]. However, previous experiments suggesting APC-inde-
pendent Cdc20 turnover were performed with temperature-
sensitive APC mutants, which do not necessarily eliminate all
APC function. Although the APC is normally essential, we
have previously shown that deletion of genes encoding two
Cdc20 substrates, Pds1 and Clb5, combined with 10-fold
overexpression of the Cdk inhibitor Sic1 (SIC110x), allows cells
to survive in the absence of the APC [31]. To determine
whether Cdc20 turnover is dependent upon a functional
APC, we examined Cdc20 turnover in an apc11D pds1D
Figure 1. Cdc20 Is Turned Over by the Anaphase-
Promoting Complex by Cdh1-Dependent and Cdh1-
Independent Mechanisms
(A) Diagrams of Cdc20 and Cdh1. Red, purple, blue, and
green boxes represent the D boxes, the C box (CB), the
WD40, and the C-terminal isoleucine-arginine (IR),
respectively.
(B) Three possible mechanisms of Cdc20 turnover:
Cdh1trans, Cdc20trans, and Cdc20cis.
(C) Asynchronous pds1D clb5D SIC110x cells were
collected at indicated time points after cycloheximide
addition. Blots were probed with antibodies against
Cdc20, Clb2, and Cdc28, which served as a loading
control.
(D) Anaphase-promoting complex (APC) immunopurified
from tandem affinity purification (TAP)-Cdc16 lysates in
a cdh1D background was used in ubiquitination reac-
tions using in vitro translated (IVT) ZZ-tagged 35S-methi-
onine-Cdc20 purified from rabbit reticulocyte lysates
using immunoglobin G beads. APC (++) and (+) are
5 nM and 1 nM final concentrations, respectively. Con-
trols show the dependence on the presence of exoge-
nous E1/E2(Ubc4)/methyl-ubiquitin mix and the APC.
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1871clb5D SIC110x strain. Deletion of APC11, which encodes the
essential RING finger subunit of the APC [32], abolishes APC
activity in the cell. We found that, as with the known APC
substrate Clb2 [33], turnover of Cdc20 was eliminated in the
apc11D strain (Figure 1C). This strongly suggests that, under
normal conditions, the majority of Cdc20 turnover depends
on APC activity.
We postulated that there could be three modes of APC-
dependent Cdc20 turnover (Figure 1B). First, as previously
suggested, Cdh1 bound to the APC as an activator could
recognize Cdc20 as a substrate through Cdc20’s D box
(Cdh1trans) [22–24]. However, we found previously that
whereas Cdc20 levels were slightly increased in cdh1D cells,
they were more dramatically increased in Apc2 cells [25], sug-
gesting that the APC targets Cdc20 by Cdh1-independent
mechanisms as well. Consistent with this, we observed
APC-dependent ubiquitination of Cdc20 both in the presence
and absence of Cdh1 in vitro (Figure 1D).
There are two distinct mechanisms by which Cdh1-in-
dependent ubiquitination could occur. The first is similar to
the Cdh1trans mechanism. Here, one molecule of Cdc20associates with the APC as an activator and
this APC-Cdc20 complex binds a second
Cdc20 molecule as a substrate through a
WD40/D-box interaction (Cdc20trans, Fig-
ure 1B). Alternatively, a single Cdc20 molecule
bound to the APC as an activator could be
ubiquitinated directly by the APC (Cdc20cis,
Figure 1B).
Contribution of the Cdh1-Dependent
and Independent Mechanisms
to Cdc20 Turnover
We found previously that mutation of Cdc20’s
IR motif increased steady-state Cdc20 levels
[25], consistent with a Cdh1-independent
mechanism for Cdc20 turnover. This increase
in steady-state level is higher than that ob-
served for wild-type Cdc20 in a cdh1D strain,
suggesting that the Cdh1-independent mech-
anism is responsible for the majority of Cdc20turnover (Figure 2A, lanes 5 and 9) [25]. The IRD and cdh1D
double mutant was more stable than either single mutant,
consistent with multiple mechanisms controlling Cdc20
stability (Figure 2A, lanes 5–16). Because mutation of the IR
decreases Cdc20 binding to the APC (data not shown), both
Cdc20trans and Cdc20cis could, in principle, be affected.
Consistent with this idea, we found that mutation of the IR
had no effect on Cdh1-dependent ubiquitination in vitro (see
Figure S1A available online) but greatly inhibited autoubiquiti-
nation (Figure 2B, lanes 9–12).
To further assess the contribution of the Cdh1trans mecha-
nism in isolation, we sought to create a Cdc20 mutant that
was defective in binding to the APC as an activator but could
be bound as a substrate through its D boxes. The observation
that mutation of Cdc20’s IR motif has no obvious growth
phenotypes is consistent with it only having a partial effect
on Cdc20 binding to the APC. Mutation of C box, however, is
lethal and decreases Cdc20 binding to the APC [8, 25], sug-
gesting that C-box mutations greatly reduce interaction
with the APC. Therefore, we expected a C-box mutation
to eliminate Cdc20cis and Cdc20trans mediated turnover. The
Figure 2. Cdc20 Ubiquitination and Turnover in cdc20, cdh1 Mutants
(A) Asynchronous PDS1 CLB5 SIC1 cells were treated with cycloheximide,
and samples were analyzed as in Figure 1C. Cdc20-IR denotes the
Cdc20-DIR allele.
(B) ZZ-tagged 35S-Cdc20 wild-type, C-box mutant (I147A, P148A) or IR
mutant (I609A, R610A) were generated by IVT and incubated with APC
(5 nM) and E1/E2(Ubc4)/methyl-ubiquitin mix for the indicated times.
Quantifications are shown below.
(C) Asynchronous pds1D clb5D SIC110x cells were treated with cyclohexi-
mide and analyzed as in Figure 1C. Cdc20-CB denotes the Cdc20-R145D
allele. Cdc20-R145D (Cdc20-CB) protein migrates more slowly on an elec-
trophoretic gel as compared to wild-type Cdc20.
(D) ZZ-tagged unlabeled Cdc20 wild-type, C-box mutant I147A, P148A
(Cdc20-CB) or IR mutant I609A, R610A (Cdc20-IR), or a mock purification
from IVT lysate with no Cdc20 (2) was preincubated with APC (5 nM)
and ZZ-tagged 35S-securin generated by IVT. After a 15 min preincubation,
E1/E2(Ubc4)/methyl-ubiquitin mix was added and ubiquitination reactions
were performed for the indicated times. See also Figure S1.
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1872minimal conserved sequence of the C box in both Cdc20 and
Cdh1 is DRYIP [8]. Previously, we characterized two C-box
mutants, a weaker cdc20-I147A,P148A allele and a stronger
cdc20-R145D allele (which did not translate well in vitro) [25].
We examined the turnover of Cdc20-R145D in a cdh1D strain.
Surprisingly, whereas the known Cdc20 substrate Dbf4 was
stabilized, the Cdc20-R145D protein was still turned over
rapidly, although there was an increase in steady-state levels
(Figure 2C, lanes 4–9; Figure S1B). It was possible that this
mutation did not entirely eliminate C-box function, so we
also analyzed a cdc20-D144R, R145D double mutant. Thismutant turned over with similar kinetics to the cdc20-R145D
allele (Figure S1C).
We also observed that the I147A, P148A C-box mutant had
a larger effect than the IR mutation on securin ubiquitination
in vitro (Figure 2D, lanes 7–12). Yet the defect observed with
the same C-box mutation is less severe than that observed
with the IR mutant in autoubiquitination activity (Figure 2B,
lanes 5–12). Thus, although theC box is essential for APC func-
tion in vivo, considerable Cdc20 turnover occurs when the C
box is mutated. Our results, together with previous evidence
that the C box, but not the IR, is essential for viability, indicate
that the C box is more important than the IRmotif for substrate
turnover and less critical for Cdc20 autoubiquitination.
Because neither the IR nor C-box mutation alone eliminated
Cdh1-independent turnover, we generated a C box, IR double
mutant. Cdc20-IR, R145D should not be able to interact with
the APC as an activator and therefore should eliminate both
the Cdc20trans and Cdc20cis mechanisms of turnover. Consis-
tent with this, the Cdc20-IR, R145D mutant was strongly
stabilized in a cdh1D strain but could be turned over in a
CDH1 strain (Figure 3A, lanes 7–9 and 13–15). Similarly, we de-
tected ubiquitination of a Cdc20-C-box-IR mutant in the pres-
ence of Cdh1 in vitro, and this activity was entirely D-box
dependent (Figure 3B, lanes 1–6). These results are consistent
with previously suggested model that Cdh1 can target Cdc20
[22–24]. However, the dramatic increase in steady-state levels
and the relatively slow rate of turnover in the Cdh1trans-only
strain suggests that Cdh1-dependent turnover likely contrib-
utes to a small portion of normal Cdc20 turnover (Figure 3A,
lanes 7–9).
We next sought to investigate whether the Cdc20trans mech-
anism makes any contribution to Cdh1-independent turnover.
We generated a cdh1D strain containing a wild-type copy of
CDC20 and the cdc20-IR, R145D allele at a second locus.
Turnover of Cdc20-IR, R145D should be defective in both the
Cdh1trans and Cdc20cis mechanisms in this strain and should
therefore be turned over exclusively by Cdc20trans. This
Cdc20-IR, R145D mutant was slightly more stable than that
observed in the Cdh1trans-only strain, suggesting that the
Cdc20trans mechanism does occur but likely contributes very
little to Cdh1-independent turnover (Figure 3A, lanes 10–12).
To further characterize the Cdc20trans mechanism, we tested
whether a wild-type copy of Cdc20 can ubiquitinate this
double mutant in vitro. We detected very little ubiquitination
of this mutant in the presence of a wild-type copy of Cdc20,
and the little stimulation seen over background was D-box
dependent (Figure 3C, lanes 4–6 and 10–12). Interestingly,
although this D box appears Cdh1-specific in terms of target-
ing Cdc20 as a substrate in vitro, we did see a slight defect
with thismutant both in direct binding to the APC and in target-
ing securin for ubiquitination in vitro, suggesting that Cdc20’s
D box may have an additional function (data not shown).
Given that total Cdc20 turnover appeared significantly faster
than turnover via either Cdc20trans or Cdh1trans, we examined
the contribution of the Cdc20cis mechanism using an allele of
Cdc20 that could only be bound to the APC as an activator
and not as a substrate. We generated a cdh1D strain in which
the only copy of Cdc20 is mutated at its first D box (cdc20-DB)
and thus cannot function as a substrate in a Cdc20trans reac-
tion. In this strain, where only Cdc20cis turnover occurs,
Cdc20 turnover is quite fast, and steady-state Cdc20 levels
are low, similar to those in a cdh1D strain where both Cdh1-
independent mechanisms can occur (Figure 3D, lanes 1–8).
These data suggest that Cdc20cis is the dominant form of
Figure 3. The Majority of Cdc20 Turnover Occurs by the Cdc20cis Mechanism
(A) Asynchronous pds1D clb5D SIC110x cells were analyzed as in Figure 2C. Cdc20-CB denotes the Cdc20-R145D, IRD allele. Bands represented by Cdc20
and Cdc20-CB are indicated. Two exposures are shown.
(B) ZZ-tagged 35S-Cdc20 C box, IR mutant (I147A, P148A, I609A, R610A) or 35S-Cdc20 C box, IR, D-box mutant (I147A, P148A, I609A, R610A, R17A, L20A)
was incubated with recombinant Cdh1, APC (1 nM), and E1/E2(Ubc4)/methyl-ubiquitin mix for the indicated times.
(C) IVT-generated ZZ-tagged 35S-Cdc20 mutants, as in (B), were incubated with APC (5 nM), E1/E2(Ubc4)/methyl-ubiquitin mix, and with or without
IVT-generated ZZ-tagged unlabeled Cdc20 for the indicated times.
(D) Asynchronous pds1D clb5D SIC110x cells were treated with cycloheximide and examined as in Figure 2C. Bands labeled Cdc20* are Cdc20 or Cdc20
D-box allele (cdc20-R17A, L20A), whereas Cdc20-CB* indicates the Cdc20-IRD, R145D allele or Cdc20-R145D, IRD, D-box (R17A, L20A) allele.
(E) Securin and Cdc20 ubiquitination assays as in Figure 2B, except that APC was purified from DOC1 cdh1D or doc1-4A cdh1D strains.
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Figure 4. Cdc20 Levels Oscillate with the Cell Cycle in a Cdh1- and Transcription-Independent Manner
(A) Asynchronous cdc15-2 or cdc15-2 cdh1D cells were arrested at 37C and released into 23C media. Time points were taken every 20 min. A sample of
each asynchronous (Asy) culture and a cdc20D mutant are shown for reference.
(B) cdc15-2 TEF1p-CDC20 or cdc15-2 TEF1p-CDC20 cdh1D strains were arrested and released as in (A). Time points were taken every 10min.Western blots
were performed with the indicated antibody. See also Figure S2.
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small (Figure 3D, lanes 9–12).
To determine the extent to which the first D-box mutation
eliminates Cdc20trans turnover in vivo, we examined its effect
in our strain that uses Cdc20trans exclusively (see Figure 3A,
lanes 10–12). We found that Cdc20-IR, R145D, DB was
extremely stable in a CDC20 cdh1D strain, although a very
low level of turnover did occur (Figure 3D, lanes 13–16). Muta-
tion of a second N-terminal D box had no additional effect
(data not shown). Thus, the D-box mutation eliminated in trans
turnover, consistent with previous reports [21, 29]. These data
suggest that Cdc20cis is the dominant form of Cdc20 turnover,
with the contribution of Cdc20trans being very small (Figure 3D,
lanes 5–8 and 9–12).
The nonessential APC subunit Doc1 (APC10) is thought to
interactdirectlywith theDboxof substratesandenhanceproc-
essivity by limiting the dissociation rate of the substrate [14, 18,
19]. Deletion of this subunit or mutation of four residues (Doc1-
4A)within its putative substratebinding site leads toadecrease
in thenumberof ubiquitinsconjugated to thesubstrate, as visu-
alized by a significant decrease in higher molecular weight
substrate-ubiquitin bands and accumulation of monoubiquiti-
nated substrate (Figure 3E, lanes 1–8) [19]. Cdc20 contains
a D box that has been shown to be important in Cdh1-depen-
dentubiquitination [21].We testedwhetheraDoc1/D-box inter-
action was required for processive ubiquitination of Cdc20
in vitro in the absence of Cdh1. Unlike our results with all other
substrates tested, mutation of Doc1 had no effect on the proc-
essivity of this reaction. Doc1 andDoc1-4Ahad nearly identical
activity toward Cdc20 (Figure 3E, lanes 9–16), implying that
Doc1 is not required for Cdh1-independent ubiquitination of
Cdc20. These data strongly suggest that Cdc20 is not ubiquiti-
nated by the APC as a canonical substrate and can best be
explained by the Cdc20cis mechanism of autoubiquitination.
Cdc20 Levels Oscillate Independently of Cdh1 and Cdc20
Transcriptional Oscillation
Cdh1 activity is cell cycle regulated, which contributes to
Cdc20 periodicity. We sought to determine whether Cdh1-
independent mechanisms are also important for oscillations
in Cdc20 levels. Because cdh1D cells do not arrest well in
alpha factor, we examined Cdc20 levels through the cell cycle
using cdh1D cdc15-2 cells. Cells were arrested at the nonper-
missive temperature in anaphase and released into thepermissive temperature. Consistent with a recent report, we
found that Cdh1 is not necessary for Cdc20 levels to fluctuate
with the cell cycle [26] (Figure 4A; Figure S2A).
To examine the extent to which oscillations in CDC20 tran-
scription contribute to the fluctuation of Cdc20 levels, we
generated a strain with CDC20 under the control of a constitu-
tive promoter (TEF1p). Cdc20 levels were still periodic in this
strain. Moreover, Cdh1 was not required for this periodicity
(Figure 4B; Figure S2B). Whereas Cdh1-dependent turnover
of Cdc20 and cell cycle regulated transcription both contribute
to Cdc20 cycling, Cdh1-independent turnover mechanisms
appear to add significantly to Cdc20 oscillation.
Substrates Inhibit Autoubiquitination
If Cdc20 targets itself while bound to the APC as an activator,
then how does the cell maintain Cdc20 levels sufficient to
trigger anaphase? We tested the possibility that the binding
of substrates to Cdc20 might inhibit autoubiquitination, main-
taining Cdc20 stability until its targets are depleted in ana-
phase. We generated an N-terminal fragment (aa1–110) of
budding yeast securin, containing the characterized de-
struction motif [11]. As expected for a competitive inhibitor,
this fragment potently inhibited securin ubiquitination
(IC50 w200 nM) (Figure 5A). A 10 mM concentration of the se-
curin fragment completely inhibited ubiquitination of securin
(Figure 5A). This concentration of the fragment also inhibited
the total activity and processivity of Cdc20 autoubiquitination
(Figure 5B). These results support the notion that substrate
blocks autoubiquitination, prolonging Cdc20 levels in the cell
until substrates are depleted (Figure 6).
Discussion
One of the first APC substrates to be identified was its own
activator, Cdc20, hinting at the existence of autoregulation
[21, 29]. Initial reports suggested that Cdc20 behaved similarly
to other APC substrates, being targeted in part via a different
activator (Cdh1) through Cdc20’s D box [22–24]. Interestingly,
we show here that, unlike other APC substrates, Cdc20 is
largely targeted for destruction by the APC through an autou-
biquitination mechanism that occurs when Cdc20 is bound to
the APC as an activator. Importantly, this mechanism appears
to be regulated throughout the cell cycle and may be influ-
enced by the presence or absence of substrates.
Figure 5. Cdc20cis Mechanism Is Inhibited by High
Substrate Concentrations
(A) ZZ-tagged unlabeled Cdc20 generated by IVT was
preincubated with APC (5 nM) and the specified con-
centration of the securin/Pds1 fragment (referred to as
securin 1–110; values represent the final assay concen-
trations). After a 15 min preincubation, E1/E2(Ubc4)/
methyl-ubiquitin mix and ZZ-tagged 35S-securin gener-
ated by IVT was added and ubiquitination reactions
were performed for 10 min.
(B) ZZ-tagged unlabeled Cdc20 or 35S-Cdc20 generated
by IVT was preincubated for 15 min with APC (5 nM) and
10 mM securin 1–110. For securin ubiquitination, E1/
E2(Ubc4)/methyl-ubiquitin mix and ZZ-tagged 35S-se-
curin generated by IVT was added for 10 min. For autou-
biquitination, E1/E2(Ubc4)/methyl-ubiquitin mix was
added for 10 min.
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reduced in conditional APCmutants led some authors to spec-
ulate that the residual turnover observedmight bemediated by
an APC-independent pathway. Our work in a strain that
permits the deletion of the APC11 gene shows that in unper-
turbed cells, Cdc20 is turned over solely by the APC. This
discrepancy is likely due to the fact that conditional alleles
may not be completely null for APC activity, whereas deletion
of the gene encoding the catalytic subunit (APC11) eliminates
activity completely.
APCCdh1 has long been assumed to be the APC complex
that targets Cdc20 for destruction (Cdh1trans, Figure 1B)
[17, 22–24]. However, deletion of APC11 leads to much greater
steady-state levels of Cdc20 than deletion of CDH1, suggest-
ing the existence of other APC-mediated mechanisms [25].
This suggests two obvious models for turnover. First, Cdc20
bound to the APC as an activator could recognize another
molecule of Cdc20 leading to ubiquitination of the substrate
Cdc20 (Cdc20trans, Figure 1B). In this case, the substrate
Cdc20 should behave similarly to other Cdc20 substrates.
Alternatively, Cdc20 may bind to the APC as an activator and
this binding alone may be sufficient for autoubiquitination
(Cdc20cis, Figure 1B). To evaluate the relative contributions
of the three possible modes of Cdc20 turnover, we generated
strains in which only one mechanism of turnover was possible
and performed in vitro experiments with similar perturbations.
These experiments strongly suggested that Cdc20cis is the
predominant form of Cdc20 turnover.
Previous work showed that Cdc20 not only recruits sub-
strates to the APC but also serves to activate the APC,
because its presence was also required for the ubiquitination
of the APC substrate Nek2A, which can bind the APCindependently of an activator [9, 34]. Impor-
tantly, these results suggested that an
N-terminal fragment of Cdc20 containing the
C box was sufficient to activate the APC
toward Nek2A and that the C box was required
for this activation [9]. Interestingly, we find that
a Cdc20 C-box mutant, which does not sup-
port viability and is unable to drive Dbf4 turn-
over in vivo [25](Figure 2C), is still targeted for
turnover by the APC, although its turnover is
compromised. This result suggests that the C
box is not absolutely required for APC activity
but is specifically required for stimulating
APC activity toward other APC substrates,potentially by properly orientating either the substrate and or
the catalytic arm of the APC so substrate ubiquitination can
occur. Interestingly, deletion of the C-terminal IR domain,
which does not result in a growth defect, has a significant
effect on Cdc20 turnover, slightly greater than the defect
seen for the lethal C-box mutant. The IR domain has been
shown to interact with Cdc27, the terminal subunit of the tetra-
tricopeptide repeats (TPR) arm of the APC [13, 25, 35]. The
nonessential nature of the IR-Cdc27 interaction could suggest
that it is an intermediate in the reaction mechanism when
Cdc20 is particularly susceptible to autoubiquitination. Con-
sistent with this observation, this interaction is not required
for the processive ubiquitination of other APC substrates
[35]. However, the lack of affinity provided by the Cdc27-IR
interaction may be compensated by an interaction between
the activator, substrate, and Doc1 on the APC core. Cdc20
autoubiquitination, however, does not require Doc1, poten-
tially making the affinity provided by the Cdc27-IR interaction
more important for Cdc20 autoubiquitination.
The discovery that Cdc20 is targeted for turnover by Cdh1,
which is itself cell cycle regulated, suggested a mechanism
by which Cdc20’s cyclical expression could be achieved.
Work from the Cross laboratory [26] and from experiments
presented here suggests that Cdh1 may contribute to but is
not necessary for Cdc20’s cell cycle oscillation. However,
previous work [21] suggested that oscillation in Cdc20 levels
is also achieved by transcriptional regulation. CDC20 is a
member of theCLB2 cluster of genes [36], whose transcription
is under the control of Fkh2/Ndd1 [37, 38]. The observation
that Cdc20 levels still oscillate in cells that express CDC20
under a constitutive promoter (TEF1p) in the absence of
Cdh1 implies an additional cell cycle regulated mechanism.
Figure 6. Model Demonstrating How Cdc20cis May Be Regulated by
Substrate
Red, purple, blue, and green boxes represent the D boxes, the C box, the
WD40, and the C-terminal IR of Cdc20, respectively (see Figure 1A).
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nism we observe is sufficient to drive the oscillatory behavior
of Cdc20 throughout the cell cycle.
Previous work has shown that phosphorylation of the TPR
subunits (Cdc27, Cdc16, and Cdc23) by the cyclin-dependent
kinase (CDK) increases the affinity of Cdc20 for the APC [39].
It is possible that these phosphorylations are regulating
the Cdc20cis mechanism. However, these phosphorylations
promote Cdc20 binding to the APC and occur when CDK
activity is high. If these phosphorylations are promoting the
Cdc20cis turnover during the cell cycle, we would expect to
see the lowest Cdc20 levels when CDK activity is highest.
However, we observe that the lowest Cdc20 levels occur
during the G1 phase of the cell cycle, when CDK activity is
lowest. Alternatively, phosphorylation of the TPR proteins
may cause Cdc20 to bind in a slightly different position on
the APC, which may inhibit the Cdc20cis mechanism.
These data suggest the following model. The APC is hyper-
phosphorylated in early mitosis, which increases its affinity
for Cdc20. As APCCdc20 runs out of substrates, Cdc20 begins
to autoubiquitinate, constituting the majority of the late mitotic
turnover. Thismodel for the regulation of Cdc20 stability by the
presence of substrates (Figure 6) is similar to that put forth
for the ubiquitin conjugase Ube2C [40]. As cells exit mitosis,
APC becomes dephosphorylated and Cdh1 becomes active,
thus removing residual Cdc20. Additionally, our model for
substrate inhibition of Cdc20 turnover may explain why it is
advantageous for the cell to have Cdc20 binding to the APC
strongly enhanced by the presence of substrates [35, 41]. In
this way, Cdc20 would be unlikely to be prematurely degraded
when substrates are present.
Interestingly, Cdc20 turnover has been shown to increase in
the presence of spindle poisons. This turnover is dependent
on an intact spindle assembly checkpoint (SAC) [28]. The exact
mechanism for this turnover is unknown, but it will be inter-
esting to determine the mechanism for Cdc20 turnover during
SAC activation.
Experimental Procedures
Yeast Methods
Yeast were grown in Ym-1 media [42] and 2% dextrose. All cells were grown
at 23C unless otherwise noted. Cdc20 integrating plasmid was created by
cloning Cdc20 and its promoter into pRS306 using standard techniques.
Mutations to pRS306-Cdc20 were accomplished using quick change muta-
genesis. Cdc20 plasmids were integrated at theURA3 locus into derivations
of three strains: pds1D clb5D SIC110x cdc20D cdh1D, pds1D clb5D SIC110x
cdc20D CDH1, or pds1D clb5D SIC110x CDC20 cdh1D. All strains created
in this manner were checked for single integration by Southern blot.Replacement of the CDC20 promoter with TEF1p was accomplished using
standard PCR-based techniques, as was deletion of CDH1 and mutation of
Cdc20’s IR motif in Figure 2A.
Half-Life Assays
Cells were grown to saturation, diluted, and allowed to grow for at least two
doublings to an optical density (OD) between 0.6 and 1.0. Six ODs of cells
were collected for the zero time point. Cell pellets were washed with 1 ml
cold H2O and frozen on dry ice. Cycloheximide was added to cultures for
a final concentration of 50 mg/ml media. Six ODs of cells were collected
for each time point as indicated. Cell pellets processed as described below.
cdc15-2 Arrest and Release
Cells were grown to saturation, then diluted to an OD of 0.3 and allowed to
grow to an OD between 0.6 and 1.0. Six ODs of cells were collected as
described above for an asynchronous sample. Cells were diluted to an
OD of 0.5 and placed at 37C for 3 hr. Cells were examined under a micro-
scope to confirm anaphase arrest. Six ODs of cells were collected for the
zero time point, as described above. Cells were then released into media
at 23C at an OD of 0.6, and six ODs of cells were collected at time points
indicated. Cells were collected for flow cytometry at every time point and
processed [43].
Western Blots
Cell pellets were processed as follows: cell pellets were thawed in boiling
sample buffer (50 mM Tris pH 7.5, 5% SDS, 5 mM EDTA, 10% glycerol,
0.5% beta-mercaptoethanol, 0.1 mg/ml pepstatin A, 0.1 mg/ml leupeptin,
0.1 mg/ml bestatin, 0.1 mM benzamidine, 5 mM NaF, 0.5 mM Na3VO4,
40 mM b-glycerophosphate, 1 mM phenylmethylsulfonyl fluoride). Cells
were boiled for 5 min, followed by bead-beating three times, 30 s each,
and then boiled again for 5 min for SDS-PAGE and transferred to nitrocellu-
lose. Western blots were performed with low salt phosphate buffered saline
with Tween 20 (PBST) (15 mM NaCl, 1.3 mM NaH2PO4, 5.4 mM Na2HPO4,
0.05% Tween pH 6.8). All primary antibody incubations were performed
overnight in 5% milk and low salt PBST unless otherwise noted. Antibodies
were used as follows: Cdc20 (yC-20) from Santa Cruz at 1:1000, Cdc28 from
Santa Cruz (yC-20) at 1:1000, Dbf4 (yN-15) from Santa Cruz at 1:500, Clb2
(y180) from Santa Cruz 1:1000 (Figure 4B), and Cdc6 9H8/5 from Abcam
at 1:2000.
APC Assays
APC was purified from a TAP-CDC16, cdh1D strain. E1, E2 (Ubc4), APC,
and Cdh1 were expressed and purified as previously described [19, 44].
ZZ-tagged Cdc20 wild-type and mutants were transcribed and translated
in vitro with TnT Quick Coupled Transcription/Translation Systems
(Promega) either in the presence of 35S-methionine or unlabeled methio-
nine. Briefly, APC assays were performed by first charging the E2 in the
presence of E1 (Uba1, 300 nM), E2 (Ubc4, 50 mM), methyl-ubiquitin (Boston
Biochem, 150 mM), and ATP (1 mM) for 20 min. E1/E2(Ubc4)/methyl-ubiqui-
tin mix was added to APC (1–5 nM), ZZ-Cdc20 purified from reticulocyte
lysate using IgG beads and cleaved using TEV protease, and securin puri-
fied similarly from reticulocyte lysate. In Figure 2D, APC, Cdc20, and securin
were preincubated to increase the amount of activity observed for the
mutants. For Figures 5A and 5B, histidine (His)-tagged securin (aa1–110)
was expressed in bacteria and purified using Ni-NTA resin. After tobacco
etch virus protease cleavage to remove the His6-tag, the protein was further
purified using cation exchange and size exclusion chromatography. APC,
Cdc20, and securin (aa1–110) were preincubated before adding in vitro
translated securin and E1/E2(Ubc4)/methyl-ubiquitin mix or E1/E2(Ubc4)/
methyl-ubiquitin mix alone. All reactions were stopped by the addition of
sample buffer, separated by SDS-PAGE, and visualized and quantified
with a Molecular Dynamics PhosphorImager and ImageQuant (Amersham
Biosciences/GE Healthcare).
Supplemental Information
Supplemental Information includes two figures and can be found with this
article online at doi:10.1016/j.cub.2011.09.051.
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